Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C, Lewis R, Waters R, Huddart RA; BC2001 Investigators.

N Engl J Med. 2012 Apr 19;366(16):1477-88. doi: 10.1056/NEJMoa1106106.

PMID:
22512481
[PubMed - indexed for MEDLINE]
Free Article
2.

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DM, James ND.

Br J Cancer. 2004 Jun 1;90(11):2106-11.

PMID:
15150587
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).

Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, Crundwell M, Adab FA, Sheehan D, Syndikus I, Hendron C, Lewis R, Waters R, James ND.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9. doi: 10.1016/j.ijrobp.2013.06.2044. Erratum in: Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):860.

PMID:
23958147
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C.

JAMA. 2008 Apr 23;299(16):1914-21. doi: 10.1001/jama.299.16.1914.

PMID:
18430910
[PubMed - indexed for MEDLINE]
5.

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D.

Lancet Oncol. 2013 May;14(6):516-24. doi: 10.1016/S1470-2045(13)70086-X. Epub 2013 Apr 9.

PMID:
23578724
[PubMed - indexed for MEDLINE]
Free Article
6.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
[PubMed - indexed for MEDLINE]
7.

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L.

J Natl Cancer Inst. 1996 May 1;88(9):583-9.

PMID:
8609658
[PubMed - indexed for MEDLINE]
Free Article
8.

Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.

Chen WC, Liaw CC, Chuang CK, Chen MF, Chen CS, Lin PY, Chang PL, Chu SH, Wu CT, Hong JH.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):726-33.

PMID:
12788178
[PubMed - indexed for MEDLINE]
9.

Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.

Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.

Cancer. 2004 Dec 1;101(11):2540-8.

PMID:
15481058
[PubMed - indexed for MEDLINE]
Free Article
10.

Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.

Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.

Cancer. 1998 Mar 1;82(5):918-22.

PMID:
9486582
[PubMed - indexed for MEDLINE]
11.

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND.

Ann Oncol. 2001 Jul;12(7):929-35.

PMID:
11521797
[PubMed - indexed for MEDLINE]
Free Article
12.

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.

[No authors listed]

Lancet. 1999 Aug 14;354(9178):533-40. Erratum in: Lancet 1999 Nov 6;354(9190):1650.

PMID:
10470696
[PubMed - indexed for MEDLINE]
13.

Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy.

Sanguineti G, Orsatti M, Sormani MP, Canobbio L, Curotto A, Tognoni P, Giudici S, Franzone P, Boccardo F, Vitale V.

Cancer J Sci Am. 1997 Jul-Aug;3(4):213-23.

PMID:
9263627
[PubMed - indexed for MEDLINE]
14.

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.

Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH.

J Natl Cancer Inst. 2010 Aug 4;102(15):1188-98. doi: 10.1093/jnci/djq258. Epub 2010 Jul 15.

PMID:
20634482
[PubMed - indexed for MEDLINE]
Free Article
15.

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.

Sengeløv L, von der Maase H, Lundbeck F, Barlebo H, Colstrup H, Engelholm SA, Krarup T, Madsen EL, Meyhoff HH, Mommsen S, Nielsen OS, Pedersen D, Steven K, Sørensen B.

Acta Oncol. 2002;41(5):447-56.

PMID:
12442921
[PubMed - indexed for MEDLINE]
16.

Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.

J Natl Cancer Inst. 2011 Dec 7;103(23):1761-70. doi: 10.1093/jnci/djr432. Epub 2011 Nov 4.

PMID:
22056739
[PubMed - indexed for MEDLINE]
Free Article
17.

Radiotherapy is an effective treatment for high-risk T1-bladder cancer.

Rödel C, Dunst J, Grabenbauer GG, Kühn R, Papadopoulos T, Schrott KM, Sauer R.

Strahlenther Onkol. 2001 Feb;177(2):82-8; discussion 89.

PMID:
11233839
[PubMed - indexed for MEDLINE]
18.

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.

Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED; Southwest Oncology Group Trial 8733.

Cancer. 2008 May 15;112(10):2181-7. doi: 10.1002/cncr.23420.

PMID:
18404692
[PubMed - indexed for MEDLINE]
Free Article
19.

Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.

Peyromaure M, Slama J, Beuzeboc P, Ponvert D, Debré B, Zerbib M.

Urology. 2004 Jan;63(1):73-7. Review.

PMID:
14751352
[PubMed - indexed for MEDLINE]
20.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC; EORTC Radiotherapy Group Trial 22921.

N Engl J Med. 2006 Sep 14;355(11):1114-23. Erratum in: N Engl J Med. 2007 Aug 16;357(7):728.

PMID:
16971718
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk